Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Axonics Modulation Technologies, Inc.    AXNX

AXONICS MODULATION TECHNOLOGIES, INC.

(AXNX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/15/2021 01/19/2021 01/20/2021 01/21/2021 01/22/2021 Date
51.7(c) 51.65(c) 50.8(c) 54.31(c) 56.55(c) Last
386 593 583 989 312 915 999 558 734 677 Volume
-1.99% -0.10% -1.65% +6.91% +4.12% Change
More quotes
Financials (USD)
Sales 2020 112 M - -
Net income 2020 -55,9 M - -
Net cash position 2020 257 M - -
P/E ratio 2020 -37,3x
Yield 2020 -
Sales 2021 157 M - -
Net income 2021 -48,2 M - -
Net cash position 2021 221 M - -
P/E ratio 2021 -46,3x
Yield 2021 -
Capitalization 2 251 M 2 251 M -
EV / Sales 2020 17,8x
EV / Sales 2021 12,9x
Nbr of Employees 302
Free-Float 78,6%
More Financials
Company
Axonics Modulation Technologies, Inc. is a medical technology company. The Company is focused on the design, development, and commercialization of sacral neuromodulation (SNM) solutions. SNM therapy is primarily used to treat patients with overactive bladder (OAB), fecal incontinence (FI), and urinary retention (UR). Its rechargeable SNM system (r-SNM System) delivers mild electrical pulses to the targeted sacral... 
More about the company
Notations Surperformance© of Axonics Modulation Technologies, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about AXONICS MODULATION TECHNOLOGIES, INC.
2020AXONICS MODULATION TECHNOLOGIES, INC : Change in Directors or Principal Officers..
AQ
2020AXONICS MODULATION TECHNOLOGIES : ® Announces Appointment of David M. Demski to ..
BU
2020AXONICS MODULATION TECHNOLOGIES : ® to Participate in Piper Sandler Virtual Heal..
BU
2020AXONICS MODULATION TECHNOLOGIES : ® Announces Publication of Fecal Incontinence ..
BU
2020AXONICS MODULATION TECHNOLOGIES : Corporate Presentation
PU
2020Wells Fargo Adjusts Price Target on Axonics Modulation Technologies to $57 Fr..
MT
2020Truist Adjusts Price Target on Axonics Modulation Technologies to $58 From $5..
MT
2020Piper Sandler Adjusts Axonics Modulation Technologies PT to $57 From $50, Mai..
MT
2020Needham Adjusts Price Target on Axonics Modulation Technologies to $62 From $..
MT
2020Axonics Modulation's Q3 Loss Shrinks, Revenue Surges; Results Top Estimates; ..
MT
2020AXONICS MODULATION TECHNOLOGIES, INC : Results of Operations and Financial Condi..
AQ
2020AXONICS MODULATION TECHNOLOGIES : ® Reports Third Quarter 2020 Results
BU
2020Earnings Flash (AXNX) AXONICS MODULATION TECHNOLOGIES Reports Q3 Revenue $35...
MT
2020LYRA THERAPEUTICS : Appoints Nancy L. Snyderman to Its Board of Directors
AQ
2020AXONICS MODULATION TECHNOLOGIES : ® Submits PMA Supplement to FDA to Further Exp..
BU
More news
News in other languages on AXONICS MODULATION TECHNOLOGIES, INC.
2020AXONICS MODULATION TECHNOLOGIES : ® gibt Ergebnisse einer Erhebung bei Patienten..
2020AXONICS MODULATION TECHNOLOGIES : ® publie les résultats cliniques sur 2 ans de ..
2020AXONICS MODULATION TECHNOLOGIES : ® berichtet 2-Jahres-Ergebnisse aus der ARTISA..
2020AXONICS MODULATION TECHNOLOGIES : NICE recommande le système Axonics® r-SNM pour..
2020AXONICS MODULATION TECHNOLOGIES : NICE empfiehlt Axonics® r-SNM System zur Behan..
More news
Analyst Recommendations on AXONICS MODULATION TECHNOLOGIES, INC.
More recommendations
Chart AXONICS MODULATION TECHNOLOGIES, INC.
Duration : Period :
Axonics Modulation Technologies, Inc. Technical Analysis Chart | AXNX | US05465P1012 | MarketScreener
Technical analysis trends AXONICS MODULATION TECHNOLOGIES, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Average target price 62,33 $
Last Close Price 56,55 $
Spread / Highest target 36,2%
Spread / Average Target 10,2%
Spread / Lowest Target 0,80%
EPS Revisions
Managers and Directors
NameTitle
Raymond Wayne Cohen Chief Executive Officer & Director
Danny L. Dearen President & Chief Financial Officer
Michael H. Carrel Chairman
Rinda K. Sama Chief Operating Officer
Guang Qiang Jiang Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
AXONICS MODULATION TECHNOLOGIES, INC.13.28%2 251
STRYKER CORPORATION-2.09%90 163
SMITH & NEPHEW PLC9.50%19 774
INSPIRE MEDICAL SYSTEMS, INC.17.40%5 948
VENUS MEDTECH (HANGZHOU) INC.14.67%4 946
GLAUKOS CORPORATION15.83%3 917